2026-01-22 - Analysis Report
**Goldman Sachs (GS) Analysis Report**

**Company Overview**
Goldman Sachs is a multinational investment bank and financial services company.

**Return Rate Comparison**

* Cumulative return of GS: **180.82%**
* Cumulative return of VOO: **91.55%**
* Divergence: **90.20**
* Relative divergence: **97.10%**

The cumulative return of GS is significantly higher than VOO, indicating a divergent trend.

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | -15.0% | 17.2% | -20.0% | 1.3 | 50.6B |
| 2017-2019  | -18.0% | 17.2% | -36.0% | 1.2 | 69.6B |
| 2018-2020  | -13.0% | 18.4% | -34.0% | 1.2 | 79.8B |
| 2019-2021  | 52.0% | 18.4% | 8.0% | 1.2 | 115.8B |
| 2020-2022  | 21.0% | 32.2% | 23.0% | 1.1 | 104.0B |
| 2021-2023  | 35.0% | 32.2% | 34.0% | 1.0 | 116.8B |
| 2022-2024  | 44.0% | 23.8% | 25.0% | 1.0 | 173.3B |
| 2023-2025  | 116.0% | 27.1% | 54.0% | 1.2 | 266.1B |

The Alpha and Beta values indicate a mix of under and overperformance in various periods, with the stock's market capitalization increasing significantly.

**Recent Stock Price Fluctuations**

* Close: **$953.01**
* Last-market: {'price': 953.01, 'previousClose': 943.37, 'change': 1.02}
* 5-day SMA: **$953.38**
* 20-day SMA: **$928.09**
* 60-day SMA: **$856.58**

The recent market price is above the 5-day SMA, but below the 20-day and 60-day SMAs.

**RSI, PPO Index Indicators and Delta**

* Market Risk Indicator (MRI): **0.80** (High Investment Recommended)
* RSI: **65.63**
* PPO: **-0.16**
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium (MRI 0.80)
* Recent (20 days) relative divergence change: **+1.40** (improving)
* 7-day Rank change: **+10** (rank up)
* 7-day Dynamic Expected Return change: **+0.30** (improving)
* If the recent market price is large, there may be issues with sharp rebound or decline.

The RSI is moderately high, indicating a potentially overbought condition. The PPO is slightly negative, suggesting a possible decline. The MRI suggests that the stock is suitable for high-risk investment.

**Expected Return and Excess Return**

* Expected Return: **3.90%** (compared to S&P 500)
* Expected excess return compared to S&P 500: **3.90%**

This indicates that the stock is expected to perform relatively better than the S&P 500 in the long term.

**Recent News & Significant Events**

* Insider Sale: Director at GS Sells 729 Shares - Quiver Quantitative
* David Viniar (Goldman Sachs) sells $3.29 million in GS stock - Investing.com Australia
* The Goldman Sachs Group (NYSE:GS) Stock Rating Upgraded by Zacks Research - MarketBeat
* 3 Things Investors Need to Know About Goldman Sachs Stock in 2026 - The Motley Fool
* Goldman Sachs (GS) Valuation Check After Record Results Buybacks Dividend Hike And Exit From Apple Card - simplywall.st
* A Look At Goldman Sachs (GS) Valuation After Strong Multiâ€‘Period Share Price Gains - Yahoo Finance New Zealand

**Analyst Opinions**

* Analyst Consensus:
  + Key: Hold
  + Mean (1=StrongBuy~5=Sell): **2.54** (~Hold)
  + Opinions: **20**
  + Target Price (avg/high/low): **930.80** / **1125.00** / **700.00**

**Comprehensive Analysis (Summary)**

Goldman Sachs (GS) shows impressive performance in the provided data, with a significantly higher cumulative return compared to the S&P 500. The Alpha and Beta values indicate a mix of under and overperformance in various periods. The recent market price is above the 5-day SMA, but below the 20-day and 60-day SMAs. The RSI is moderately high, while the PPO is slightly negative, suggesting a potentially overbought condition. The MRI suggests that the stock is suitable for high-risk investment. The expected return and excess return suggest that the stock is expected to perform relatively better than the S&P 500 in the long term. Recent news and significant events suggest that the stock's valuation is being closely watched, with possible implications for future performance.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.